Ekso Bionics (EKSO) Set to Announce Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) is set to issue its quarterly earnings data after the market closes on Monday, April 29th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

Ekso Bionics (NASDAQ:EKSO) last issued its quarterly earnings results on Monday, March 4th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.11). Ekso Bionics had a negative net margin of 83.14% and a negative return on equity of 90.80%. The firm had revenue of $4.85 million during the quarter, compared to the consensus estimate of $4.80 million. During the same quarter last year, the firm posted ($0.24) earnings per share. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Price Performance

Shares of NASDAQ EKSO opened at $1.25 on Friday. Ekso Bionics has a twelve month low of $0.62 and a twelve month high of $3.13. The company has a current ratio of 2.49, a quick ratio of 1.87 and a debt-to-equity ratio of 0.38. The company has a market capitalization of $22.38 million, a price-to-earnings ratio of -1.14 and a beta of 1.61. The business has a 50 day simple moving average of $1.52 and a 200-day simple moving average of $1.61.

Analyst Upgrades and Downgrades

EKSO has been the subject of a number of research analyst reports. StockNews.com upgraded Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th. HC Wainwright lowered their price target on Ekso Bionics from $10.00 to $9.25 and set a “buy” rating for the company in a report on Tuesday, March 5th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.